News related to discoveries on kidney and liver diseaes:

(05/05/2012) FEHV Attends the Annual Congress of the European Society of Liver Diseases

(25/01/2012) Tenofovir response in patients with hepatitis B who do not response to entecavir

(25/01/2012) Usefulness of determination IL28-B gene to predict the evolution of liver damage

(25/01/2012) New marker for liver cancer

(25/01/2012) New compounds that inhibit hepatitis C virus infection

(08/01/2012) Usefulness of the study of the IL28-B gene to shorten the treatment of chronic hepatitis C

(10/11/2011) New article on occult hepatitis C virus infection

(10/11/2011) Pentoxifylline in fatty liver disease

(10/11/2011) News of the annual meeting of the american society for the study of liver diseases (november 4-8, 2011 San Francisco)

(12/10/2011) Dual therapy with BMS-790052 (inhibitor of the NS5A region of hepatitis C virus) and with BMS-650032 (inhibitor of the NS3 region of hepatits C virus) in non-responder patients with genotype 1b

(12/10/2011) Study of the effects of phlebotomy in patients with chronic hepatitis C

(10/10/2011) Elimination of hepatocellular carcinoma after 25 years of the introduction of vaccination program for hepatitis B in infants

(10/10/2011) PNPLA3 gene polymorphism confers increased risk of cirrhosis and liver damage in alcoholic liver disease

(03/10/2011) Natural evolution of nonalcoholic fatty liver disease

(08/09/2011) Treatment of autoimmune hepatitis with Mycophenolate

(08/09/2011) New treatment with Telaprevir plus Pegylated interferon and Ribavirin in hepatits

(20/07/2011) Pegylated-interferon, Ribavirin, and Telaprevir in hepatitis C

(14/07/2011) XLVIII ERA-EDTA Congress

(23/06/2011) Retreatment of chronic hepatitis C with Telaprevir + PEG-IFN alpha + Ribavirin

(23/06/2011) Telaprevir with PEG-IFN alpha + ribavirin in patients with chronic hepatitis C

(15/06/2011) New publication on occult hepatitis c virus infection

(09/05/2011) DANOPREVIR (protease inhibitor) treatment of chronic hepatitis C

(10/05/2011) New discovery in the treatment of fatty liver with ursodeoxycholic acid

(08/04/2011) Usefuness of the of the determination of the PNPLA3 gene polymorphism associated with liver fat accumulation

(31/03/2011) New treatment for hepatitis C